| Vial description: |
Bcl-2-modifying factor |
| Category: |
antigen |
| Raised in: |
laboratory |
| Clone: |
1 vial |
| Form: |
Purified |
| Reactivity: |
not determined |
| Purity: |
>, 90% |
| Molecular weight: |
15, 6 kDa |
| Source: |
coli, E |
| Activity: |
to be determined |
| Range: |
broad |
| Protein number: |
Q96LC9 |
| Application: |
not determined |
| Storage: |
Avoid freeze/thaw cycles, Upon delivery aliquot and store at -20°, C, C for one year, Shipped at 4° |
| Description: |
Freeze thaw will destroy a percentage in every cycle and should be avoided, C in a fridge short term in a concentrated dilution, This antibody needs to be stored at + 4° |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by acr they should be stored frozen at - 24° |
| Gene target: |
T7-tag), BMF (1-129 |
| Short name: |
T7-tag) Antibody, anti-BMF (1-129 |
| Technique: |
antibodies against human proteins, antibodies for, antibody to, Antibody |
| Label: |
tag |
| Alternative name: |
T7-detection labelled) (Antibody to), antibody to-Bcl2 modifying factor (1-129 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
BMF and IDBG-6070 and ENSG00000104081 and 90427, BMF and IDBG-646206 and ENSBTAG00000012180 and 541141, Bmf and IDBG-198160 and ENSMUSG00000040093 and 171543, Plasma membranes, protein binding, this GO :0001669 and acrosomal vesicle and cellular component this GO :0005515 and protein binding and molecular function this GO :0005737 and cytoplasm and cellular component this GO :0005741 and mitochondrial outer membrane and cellular component this GO :0005829 and cytosol and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006915 and apoptotic process and biological process this GO :0015629 and actin cytoskeleton and cellular component this GO :0016459 and myosin complex and cellular component this GO :0032464 and positive regulation of protein homooli this GO merization and biological process this GO :0043276 and anoikis and biological process this GO :0090200 and positive regulation of release of cytochrome c from mitochondria and biological process this GO :0097193 and intrinsic apoptotic signaling pathway and biological process this GO :1900740 and positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway and biological process this GO :2001234 and negative regulation of apoptotic signaling pathway and biological process this GO :2001235 and positive regulation of apoptotic signaling pathway and biological process this GO :2001244 and positive regulation of intrinsic apoptotic signaling pathway and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding, Bcl2 modifying factor |
| Identity: |
24132 |
| Gene: |
BMF |
More about : BMF |
| Long gene name: |
Bcl2 modifying factor |
| Synonyms: |
FLJ00065 |
| Locus: |
15q15, 1 |
| Discovery year: |
2004-01-16 |
| GenBank acession: |
BC060783 |
| Entrez gene record: |
90427 |
| Pubmed identfication: |
11546872 |
| RefSeq identity: |
NM_033503 |
| Classification: |
BCL2 homology region 3 (BH3) only |
| Havana BLAST/BLAT: |
OTTHUMG00000129875 |